EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 28 March 2024

News

Guidance needed to ensure EU Joint Clinical Assessment improves patient access to innovative...
28 March 2024

New study simulating proposed EU HTA methods for oncology medicines underlines need for guidance on Joint Clinical Assessment... Read more

NIRO: Navigating Innovation & Research Opportunities
28 March 2024

NIRO helps you find available European and international funds for research & innovation. Read more

Blogs

Innovative Health Initiative: improving health, improving healthcare
26 March 2024 - Magda Chlebus

From managing obesity to supporting healthier pregnancy, IHI is advancing people’s health and making health systems... Read more

Events

Unlocking the Human Element: Integrating Patient Insights & Experiences into Precision Medicine...
04 April 2024 (Virtual event)

Organised by the Patient Engagement Open Forum (PEOF), in collaboration with EFPIA and EPF. Read more

EU-X-CT Public Stakeholders' Forum
12 April 2024 (Brussels and online)

Making cross-border access to clinical trials a reality Read more

What we are reading

A Compass for Collaboration: Navigating Stakeholders’ Roles in Transitioning To Value-Based...
On 26 March 2024 (European Alliance for Value in Health)

What can each stakeholder group do, to accelerate the journey to Value-Based Healthcare?

IMI-supported treatment against drug-resistant bacteria receives positive opinion from EMA
On 22 March 2024 (IHI)

We are one step closer to treating adult patients with complicated intra-abdominal and urinary tract infections and... Read more

Diagnostic research needs recommendations
On 18 December 2023 (Rare Disease Moonshot)

The RD Moonshot partners identified three areas of action where public private collaborations can add most value.

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu